Faculty of Medical and Health Sciences


Auckland City Hospital - Neurology Research Group

In 2008, with the appointment of Professor Alan Barber as the inaugural Neurological Foundation of New Zealand Chair in Clinical Neurology, the Neurology Research Unit was established. Since this time, the NRU has expanded with the appointments of Dr Cathy Stinear, movement neuroscientist, and Dr Jennifer Pereira, clinical neurologist, as senior lecturers. In addition, the Neurological Foundation Douglas Clinical Fellowship and Dr Suzanne Ackerley, Clinical Neuroscience Research Fellow, complete the team. Professor Barber and Dr Stinear lead the Brain Recovery Clinic, the CBR research clinic at the University’s Tamaki Campus.

The NRU aims to take discoveries made in the lab and translate them into therapies for people living with the devastating effects of neurological illness. The major focus is on stroke, reflecting the current research interests of the team. This extends from epidemiology of stroke and transient ischemic attack, to new risk factors and acute therapies for stroke and new rehabilitation techniques.

Research details


Current research funding base

  • ADHB A+ Trust
  • Julius Brendel Trust
  • HRC
  • Neurological Foundation of New Zealand
  • Pharmaceutical trial funding

Current research projects

  • Auckland regional community stroke study
  • Auckland transient ischaemic attack study
  • Cannabis and stroke study
  • Echoplanar imaging thrombolysis evaluation trial
  • Neuromyelitis optica study
  • New Zealand multiple sclerosis study
  • Terminal care in stroke study
  • Cardiothoracic surgery neuroprotection trial
  • TRIO - targeted rehabilitation, improved outcomes
  • Pharmaceutical industry sponsored studies

Facilities / Technology platform

  • Auckland City Hospital, particular interest in brain imaging
  • Brain Recovery Clinic

Educational activities / community linkages

Stroke Foundation of NZ

Neurological Foundation of New Zealand

Collaborators

Professor Winston Byblow, Movement Neuroscience Group

Dr Cathy Stinear, Clinical Neuroscience Laboratory

Publications


  • Feigin VL, Barker-Collo S, Parag V, Hackett ML, Kerse N, Barber PA, Theadom A, Krishnamurthi R, on behalf of the Auckland Regional Community Stroke Study Group. Prevalence and predictors of 6-month fatigue in patients with ischemic stroke: a population-based stroke incidence study in Auckland, New Zealand, 2002-2003. Stroke. 2012;43(10):2604-2609.
  • Child N, Fink J, Jones S, Voges K, Vivian M, Barber PA. New Zealand National Acute Stroke Services Audit: acute stroke care delivery in New Zealand. NZ Med J. 2012;125(1358):44-51.
  • Stinear C, Barber PA, Petoe M, Anwar S, Byblow W. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012;135(8):2527-35.
  • Wright L, Hill KM, Bernhardt J, Lindley R, Ada L, Bajorek BV, Barber PA, Beer C, Golledge J, Gustafsson L, Hersh D, Kenardy J, Perry L, Middleton S, Brauer SG, Nelson MR, on behalf of the National Stroke Foundation Stroke Guidelines Expert Working Group. Stroke Management: updated recommendations for treatment along the care continuum. Internal Medicine Journal. 2012;42(5):562-9.
  • Davis S, Campbell B, Christensen S, Ma H, Desmond P, Parsons M, Levi C, Bladin C, Barber PA, Donnan G. Perfusion/Diffusion Mismatch Is Valid and Should Be Used for Selecting Delayed Interventions. Translational Stroke Research. 2012;3(2):188-197.
  • Wu TY, Anderson NE, Barber PA. Neurological complications of carotid revascularisation. Journal of Neurology, Neurosurgery, and Psychiatry. 2012;83(5):543-550.
  • Ma H, Parsons MW, Christensen S, Campbell BCV, Churilov L, Connelly A, Yan B, Bladin C, Phan T, Barber PA, Read S, Hankey GJ, Markus R, Wijeratne T, Grimley R, Mahant N, Kleinig T, Sturm J, Lee A, Blacker D, Gerraty R, Krause M, Desmond PM, McBride SJ, Carey L, Howells DW, Hsu CY, Davis SM, Donnan GA, on behalf of the EXTEND investigators. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). International Journal of Stroke. 2012;7(1):74-80.
  • Theadom A, Barker-Collo S, Feigin VL, Starkey NJ, Jones K, Jones A, Ameratunga S, Barber PA, on behalf of the BIONIC Research Group. The Spectrum Captured: A Methodological Approach to Studying Incidence and Outcomes of Traumatic Brain Injury on a Population Level. Neuroepidemiology 2011;38(1):18-29.
  • Barber PA, Snow B. Non-Contact First Specialist Appointments Are Safe (editorial). NZ Med J. 2011;124(1347):10-11.
  • Bradnam LV, Stinear CM, Barber PA, Byblow WD. Contralesional hemisphere control of the proximal paretic upper limb following stroke. Cerebral Cortex. Published online Dec 1, 2011. DOI:10.1093/cercor/bhr344
  • Harwood M, Weatherall M, Talemaitoga A, Barber PA, Gommans J, Taylor W, McPherson K, McNaughton H. Taking charge after stroke: promoting self-directed rehabilitation to improve quality of life – a randomized controlled trial. Clinical Rehabilitation. 2012;26(6):493-501.
  • Sheridan NF, Kenealy T, Connolly MJ, Mahony F, Barber A, Boyd MA, Carswell P, Clinton J, Devlin G, Doughty R, Dyall L, Kerse N, Kolbe J, Lawrenson R, Moffitt A. Health equity in the New Zealand health care system: a national survey.International Journal for Equity in Health. Published online 20 Oct 2011;10(1):10-45.
  • Campbell BCV, Costello C, Christensen S, Ebinger M, Parsons MW, Desmond PM, Barber PA, Butcher KS, Levi CR, De Silva DA, Lansberg MG, Mlynash M, Olivot JM, Straka M, Bammer R, Albers GW, Donnan GA, Davis SM, for the EPITHET-DEFUSE Investigators. Fluid-Attenuated Inversion Recovery Hyperintensity in Acute Ischemic Stroke May Not Predict Hemorrhagic Transformation. Cerebrovascular Diseases. 2011;32(4):401-5
  • Wu TY, Frith RW, Barber PA. Reversible Cerebral Vasoconstriction Following Carotid Endarterectomy. Journal of Clinical Neuroscience. 2011;18(12): 1725-8
  • Connolly MJ, Kenealy T, Barber PA, Carswell P, Clinton J, Dyall L, Devlin G, Doughty RN, Kerse N, Kolbe J, Lawrenson R, Moffitt A, Sheridan N. National variability in provision of health services for major long-term conditions in New Zealand (a report from the ABCC NZ study). NZ Med J. 2011;124(1344):16-35.
  • Child N, Barber PA, Fink J, Jones S, Voges K, Vivian M. New Zealand National Acute Stroke Services Audit 2009: Organisation of Acute Stroke Services in New Zealand. NZ Med J. 2011;124(1340):13-20
  • McNaughton H, Feigin V, Kerse N, Barber PA, Weatherall M, Bennett D, Carter K, Hackett M, Anderson C, on behalf of the Auckland Regional Community Stroke (ARCOS) Study Group. Ethnicity and functional outcome following stroke.Stroke. 2011; 42(4):960-964
  • Nagakane Y, Christensen S, Brekenfeld C, Ma H, Churilov L, Parsons MW, Levi CR, Butcher KS, Peeters A, Barber PA, Bladin CF, De Silva DA, Fink J, Kimber TE, Schultz DW, Muir KW, Tress BM, Desmond PM, Davis SM, Donnan GA, for the EPITHET Investigators. EPITHET: Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration. Stroke. 2011;42(1):59-64
  • Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA. Cerebral amyloid angiopathy-related inflammation: three case reports and a review. Journal of Neurology, Neurosurgery & Psychiatry. 2011;82(1):20-6
  • Johnson C, Lane H, Barber PA, Charleston A. Medication compliance in ischaemic stroke patients. Internal Medicine Journal. 2012;42(4):e47-52. E-Pub 26 Feb 2010; DOI: 10.1111/j.1445-5994.2010.02209.x.
  • Carter K, Barber PA, Shaw C. How does self-reported history of stroke compare to hospitalization data in a population-based survey in New Zealand? Stroke. 2010;41(11):2678-2680.
  • Chemmanam T, Campbell BCV, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM. Ischemic Diffusion Lesion Reversal is Uncommon and Rarely Alters Perfusion-Diffusion Mismatch.Neurology. 2010;75(12):1040-7.
  • Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010: 375(9727):1695-703.
  • Tu HTH, Campbell BCV, Christensen S, Collins M, De Silva DA, Butcher KS, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM, for the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pathophysiological Determinants of Worse Stroke Outcome in Atrial Fibrillation. Cerebrovascular Diseases.2010;30(4):389-95.
  • Ackerley SJ, Stinear CM, Barber PA, Byblow WD. Combining theta burst stimulation with training after subcortical stroke.Stroke. 2010;41(7):1568-72.
  • Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, Ebinger M, Barber PA, Bladin C, Donnan GA, Davis SM, for the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pre-treatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. Journal of Cerebral Blood Flow & Metabolism. 2010;30(6):1214-25.
  • Campbell BCV, Christensen S, Foster SJ, Desmond PM, Parsons MW, Butcher KS, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM, for the EPITHET Investigators. Visual Assessment of Perfusion-Diffusion Mismatch is Inadequate to Select Patients for Thrombolysis. Cerebrovascular Diseases. 2010;29(6):592-6.
  • De Silva DA, Brekenfeld C, Ebinger M, Christensen S, Barber PA, Butcher K, Levi C, Parsons MW, Bladin C, Donnan GA, Davis SM, for the EPITHET Investigators. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke. 2010;41(2)295-9
  • Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, Jeerakathil T, Campbell BC, Barber PA, Bladin C, Fink J, Tress B, Donnan GA, Davis SM, for the EPITHET Investigators. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010;41(1):72-7.
  • Campbell BCV, Christensen S, Butcher KS, Gordon I, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, De Silva DA, Donnan GA, Davis SM, for the EPITHET Investigators. Regional Very Low Cerebral Blood Volume Predicts Hemorrhagic Transformation Better Than Diffusion-Weighted Imaging Volume and Thresholded Apparent Diffusion Coefficient in Acute Ischemic Stroke. Stroke. 2010;41(1):82-8.
  • De Silva DA, Ebinger M, Christensen S, Parsons M, Levi CR, Butcher K,Barber PA, Bladin C, Donnan GA, Davis SM, for the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovascular Diseases. 2010;29(1):14-21.
  • Mudge S, Barber PA, Stott NS. Circuit-based rehabilitation improves gait endurance but not usual walking activity in chronic stroke: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation. 2009;90(12):1989-96.
  • Brownlee W, Fergus L, Bennett P, Gommans J, Fink J, Barber PA. Transient ischaemic attack services in New Zealand.NZ Med J. 2009;122(1299):21-7.
  • De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, Parsons M, Butcher K, Barber PA, Donnan GA, Davis SM, for the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2009;40(8):2872-4.
  • Stinear CM, Barber PA, Coxon JP, Verryt TS, Acharya PP, Byblow WD. Repetitive stimulation of premotor cortex affects primary motor cortex excitability and movement preparation. Brain Stimulation. 2009;2(3):152-162.
  • Gommans J, Barber PA, Fink J. Preventing strokes: the assessment and management of people with transient ischaemic attack. NZ Med J. 2009;122(1293):50-60.
  • Barber PA, Gommans J. How to treat stroke and TIA. NZ Doctor. April 9, 2009;19-23.
  • Ebinger M, Iwanaga T, Prosser JF, DeSilva DA, Christensen S, Collins M, Parsons MW, Levi CR, Bladin CF, Barber PA, Donnan GA, Davis SM, for the EPITHET investigators. Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke. Stroke. 2009;40(7):2572-4.
  • Ebinger M, Christensen S, DeSilva DA, Parsons MW, Levi CR, Butcher KS, Bladin CF, Barber PA, Donnan GA, Davis SM. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging endpoint. Stroke. 2009;40(4):1353-58.
  • Barber PA, Gommans J, Fink J, Hanger HC, Bennett P, Ataman N. Acute stroke services in New Zealand: changes between 2001 and 2007. NZ Med J. 2008;121(1285):46-51.
  • Anderson NE, Barber PA. Limbic encephalitis - a review. J Clin Neuroscience. 2008;15(9):961-971.
  • Gommans J, Barber PA, Hanger HC, Bennett P. Rehabilitation after stroke: changes between 2002 and 2007 in services provided by district health boards in New Zealand. NZ Med J. 2008;121(1274):26-33.
  • Stinear CM, Barber PA, Coxon JP, Fleming MK, Byblow WD. Priming the motor system enhances the effects of upper limb therapy in chronic stroke. Brain. 2008;131(Pt 5):1381-90. UI: 18356189
  • Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM, for the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurology. 2008;7(4):299-309. UI: 18296121.
  • Barber PA, Hach S, Tippett LJ, Ross L, Merry AF, Milsom P. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008;39(5):1427-33.
  • Butcher K, Parsons M, Allport L, Lee SB, Barber PA, Tress, B, Donnan GA, Davis SM for the EPITHET investigators. Rapid assessment of perfusion-diffusion mismatch. Stroke. 2008;39(1)75-81.
  • Bolland MJ, Barber PA, Doughty R, Mason B, Horne A, Ames R, Gamble GD, Grey A, Reid IR. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. British Medical Journal. 2008;336(7638):262-6.
  • Stinear CM, Fleming MK, Barber PA, Byblow WD. Lateralization of motor imagery following stroke. Clinical Neurophysiology. 2007;118(8):1794-1801
  • Stinear CM, Barber PA, Smale P, Coxon JP, Fleming MK, Byblow WD. Functional potential in chronic stroke patients depends on corticospinal tract integrity. Brain. 2007;130(Pt 1):170-180.
  • Carter KN, Anderson CS, Hackett ML, Barber PA, Bonita R on behalf of the Auckland Regional Community Stroke (ARCOS) Study Group. Improved survival after stroke: is admission to hospital the major explanation? Trends analyses of the Auckland Regional Community Stroke Studies. Cerebrovascular Diseases. 2007;23(2-3):162-8.
  • Manley P, Somerfield J, Simpson I, Barber PA, Zwi J. Bilateral uraemic optic neuritis complicating acute nephrocalcinosis. Nephrology Dialysis Transplantation. 2006;21(10):2957-8.
  • Somerfield J, Barber PA, Anderson NE, Kumar A, Spriggs D, Charleston A, Bennett P, Baker Y, Ross L. Not all patients with atrial fibrillation-associated ischemic stroke can be started on anticoagulant therapy. Stroke. 2006:37(5):1217-20.
  • Brickell KL, Anderson NE, Charleston AJ, Hope JK, Bok AP, Barber PA. Ethnic differences in syringomyelia in New Zealand. J Neurol Neurosurg Psychiatry. 2006;77(8):989-91
  • Somerfield J, Barber PA, Anderson NE, Spriggs D, Charleston A, Bennett P. Changing attitudes to the management of ischaemic stroke between 1997 and 2004: a survey of New Zealand physicians. Internal Medicine Journal. 2006;36(5):276-80.
  • Feigin V, Carter K, Hackett M, Barber PA, McNaughton H, Dyall L, Chen MH, Anderson C on behalf of the Auckland Regional Community Stroke (ARCOS) Study Group. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003. Lancet Neurology. 2006;5(2)130-9.
  • Carter K, Anderson C, Hackett M, Feigin V, Barber PA, Broad JB, Bonita R on behalf of the Auckland Regional Community Stroke (ARCOS) Study Group. Trends in ethnic disparities in stroke incidence in Auckland, New Zealand, during 1981-2003. Stroke. 2006;37(1):56-62.
  • Anderson C, Carter K, Hackett M, Feigin V, Barber PA, Broad J, Bonita R on behalf of the Auckland Regional Community Stroke (ARCOS) Study Group. Trends in stroke incidence in Auckland, New Zealand, during 1981-2003. Stroke. 2005;36(10):2087-2093.
  • Butcher K, Parsons MW, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress BM, Donnan GM, Davis SM for the EPITHET investigators. Refining the perfusion-diffusion mismatch hypothesis. Stroke. 2005;36:1153-1159.
  • McNaughton H, Barber PA, Gommans J. Nowitz M. Management problems of spontaneous intracerebral haemorrhage. Hospital Medicine. 2005;66:229-234.
  • Barber PA, Gommans J. Tissue plasminogen activator approved for stroke (editorial). NZ Med J. 2005;118(1214):U1432.
  • McAlister H, Barber PA, Clark M, Fenelon M, Fink J, Harwood M et al. The management of people with atrial fibrillation and flutter. McAlister H, ed. 2005. Wellington: New Zealand Guidelines Group.
  • Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al for the recombinant activated factor VII intracerebral haemorrhage trial investigators (incl Barber A. Principal investigator New Zealand). Recombinant activated factor VII for acute intracerebral haemorrhage. N Engl J Med. 2005;352:777-785.
  • Barber PA, Charleston AJ, Anderson NE, Spriggs DA, Bennett P, Thomas K, Baker YK. Changes in stroke care at Auckland Hospital between 1996 and 2001. NZ Med J. 2004;117 No 1190: ISSN1175 8716.
  • Barber PA, Parsons MW, Desmond PM, Donnan GM, Tress BM, Davis SM. Use of PWI and DWI Measures in the Design of “Proof of Concept” Stroke Trials. Journal of Neuroimaging. 2004:14:123-3.
  • Baskett J, McNaughton H, Anderson NE, Barber PA, Cookson T, Dady K, Fink J, et al. Life after stroke: New Zealand guideline for the management of stroke. Baskett JJ, Mc Naughton H, eds. 2003. Wellington: Stroke Foundation of New Zealand and the New Zealand Guidelines Group.
  • Barber PA, Davis SM. Limitations of current brain imaging modalities in stroke. In: Davis SM, Fisher M, Warach S, eds. MRI in Stroke. Cambridge 2003: Cambridge University Press. Chapter 2. Pages15-29.
  • Butcher K, Parsons MW, Chalk J, Barber A, Donnan GM, Desmond PM, Tress BM, Davis SM. Perfusion thresholds in acute stroke thrombolysis. Stroke. 2003;34:2159-2164.
  • Gommans J, Barber A, McNaughton H, Hanger HC, Bennett P, Spriggs D, Baskett JJ. Stroke rehabilitation services in New Zealand. NZ Med J. 2003;116 No 1174. ISSN 11758716.
  • Baird TA, Parsons MW, Barber PA, Desmond PM, G, Tress BM, Colman P, Jerrums G, Chambers B, Davis SM. The influence of diabetes mellitus and hyperglycemia on stroke incidence and outcome. J Clin Neurosci. 2003;9:618-626.
  • Gerraty RP, Parsons MW, Barber PA, Darby DG, Desmond PM, Tress BM, Davis SM. Examining the lacunar hypothesis with diffusion and perfusion MRI. Stroke. 2002;33:2019-2024.
  • Parsons MW, Barber PA, Desmond PM, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia in PWI/DWI mismatch patients leads to poorer stroke outcome. Ann Neurol. 2002;52:20-28.
  • Parsons MW, Barber PA, Darby DG, Chalk J, Rose S, Desmond PM, Gerraty RP, Tress BM, Donnan GA, Davis SM. Diffusion and perfusion weighted MRI predicts response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
  • Barber PA, Anderson NE, Bennett P, Gommans J. Acute stroke services in New Zealand. NZ Med J. 2002;115 No 1146:3-6.
  • Parsons MW, Barber PA, Davis SM. Relationship between severity of MR perfusion deficit and DWI lesion evolution (Letter). Neurology. 2002;58:1707.
  • Desmond PM, Lovell AC, Rawlinson AA, Parsons MW, Barber PA, Yang Q, Li T, Darby DG, Gerraty RP, Davis SM, Tress BM. The value of ADC maps in early cerebral ischemia. AJNR: American Journal of Neuroradiology. 2001;22:1260-1267.
  • Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion MRI maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587.
  • Baird AE, Dambrosia J, Dambrosia Q, Chaves C, Silver B, Barber PA, Parsons M, Darby D, Davis, S, Caplan LR, Edelman RR, Warach S. A three-item scale for the early prediction of stroke recovery. Lancet. 2001;357:2095-2099.
  • Hirano T, Read SJ, Abbott DF, Baird AE, Yasaka M, Infeld B, Barber PA, Davis SM, McKay WJ, Donnan GA. Prediction of the final infarct volume within 6 h of stroke using single photon emission computed tomography with technetium-99m hexamethylpropylene amine oxime. Cerebrovasc Dis. 2001;11:119-27.
  • Barber PA, Consolo HK, Darby DG, Desmond PM, Gerraty RP, Yang Q, Tress BM, Davis SM. Comparison of perfusion MRI with HM-PAO SPECT in chronic stroke. Cerebrovasc Dis. 2001;11:128-36.
  • Gerraty RP, Parsons MW, Barber PA, Darby DG, Davis SM. The volume of lacunes (Letter). Stroke. 2001;32:1937-1938.
  • Parsons MW, Li T, Barber PA, Yang Q, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Combined 1H MRS and diffusion weighted MR imaging improves the prediction of stroke outcome. Neurology. 2000;55:498-506.
  • Barber PA, Anderson NE, Vincent A. Morvan’s syndrome associated with voltage-gated K+ channel antibodies. Neurology. 2000;54:771-772.
  • Davis SM, Tress BM, Barber PA, Darby DG, Parsons M, Gerraty RP, Yang Q, Li T, Donnan, GA, Desmond PM. Echoplanar Magnetic Resonance Imaging in Acute Stroke. J Clin Neuroscience. 2000;7:3-8.
  • Darby DG, Parsons MW, Barber PA, Davis SM. Significance of acute multiple brain infarction on diffusion-weighted imaging. (Letter) Stroke. 2000:31:2266-2268.
  • Barber PA, Darby DG, Davis SM. Disturbed diffusion and X-ray hypoattenuation in acute stroke, (Letter). Stroke. 2000;31:233.
  • Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T, Jolley D, Donnan GA, Tress BM, Davis SM. Identification of major ischemic change: diffusion-weighted imaging versus computed tomography. Stroke. 1999; 30:2059-2065.
  •  
  • Yang Q, Tress BM, Barber PA, Darby DG, Gerraty RP, Desmond PM, Li T, Davis SM. Evolution of apparent diffusion coefficient and anisotropy in acute ischemic stroke. Stroke. 1999;30:2382-2390.
  • Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Jolley D, Donnan GA, Tress BM. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology. 1999;52:1125-32.
  • Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM. Pathophysiologic topography of acute ischemia using combined diffusion-weighted and perfusion MRI. Stroke. 1999;30:2043-2050.
  • Barber PA, Davis SM, Infeld I, Baird AE, Donnan GA, Jolley D, Lichtenstein M. Spontaneous reperfusion following ischemic stroke is associated with improved outcome. Stroke. 1998;29:2522-2528.
  • Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar diffusion- and perfusion-weighted magnetic resonance imaging. Neurology 1998;51:418-426.
  • Barber PA, Davis SM. Single-photon emission computed tomography-derived relative hypoperfusion volume after ischemic stroke, (Letter). Stroke. 1999;30:1733-1734.
  • Charleston AJ, Barber PA, Bennett P, Spriggs DA, Harris RG, Anderson NE. Management of stroke in Auckland Hospital in 1996. NZ Med J. 1999;112:71-74. Barber PA, Chambers ST, Parkin PJ. Australian paralysis tick bite. NZ Med J. 1994:107:252-253.